Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
Lymphoma
×
Oxaliplatin
×
Clear all
Filters
3
NCT04384484
2026-01-26
LOTIS 5
ADC Therapeutics S.A.
Phase 3
Active not recruiting
440 enrolled
NCT04182204
2025-12-22
POLARGO
Hoffmann-La Roche
Phase 3
Completed
270 enrolled
36 charts